J. Patt

Synthesis and in Vivo studies of [C-11]N-methylepibatidine: comparison of the stereoisomers.

A. Buck, P. Schubiger, G. Westera, 1999, Nuclear medicine and biology.

Comparison of in vivo dopamine D2 receptor binding of [(123)I]AIBZM and [(123)I]IBZM in rat brain.

K. Hahn, K. Tatsch, F. Gildehaus, 2001, Nuclear medicine and biology.

Neuronal nAChR stereoselectivity to non‐natural epibatidine derivatives

D. Bertrand, S. Bertrand, P. Schubiger, 1999, FEBS letters.

Synthesis and electrophysiological studies of a novel epibatidine analogue.

D. Bertrand, S. Bertrand, P. Schubiger, 1999, Journal of receptor and signal transduction research.

A new look at the neuronal nicotinic acetylcholine receptor pharmacophore.

D. Bertrand, S. Bertrand, G. Westera, 2000, European journal of pharmacology.

Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptors.

D. Bertrand, S. Bertrand, P. Schubiger, 2000, Chemistry & biology.

Comparison of N-[(11)C]methyl-norchloroepibatidine and N-[(11)C]methyl-2-(2-pyridyl)-7-azabicyclo[2.2.1]heptane with N-[(11)C]methyl-epibatidine in small animal PET studies.

P. Schubiger, G. Westera, J. Patt, 2000, Nuclear medicine and biology.

Norchloro-fluoro-homoepibatidine (NCFHEB) — A promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET

M. Patt, J. Steinbach, P. Brust, 2008, European Neuropsychopharmacology.

Synthesis and in vivo studies of the stereoisomers of N-[11C]methyl-homoepibatidine.

A. Buck, M. Arras, P. Schubiger, 2001, Nuclear medicine and biology.